Press release
Contract Research Organization (CRO) Market SWOT Analysis to 2025 Lead by IQVIA, Syneos Health, Laboratory Corporation, PRA Health Sciences, Charles River, ICON plc, WuXi AppTec,Medpace
The global contract research organization (CRO) market is expected to reach US$ 68,198.3 Mn in 2025 from US$ 35,818.9 in 2017. The market is estimated to grow with a CAGR of 8.6% from 2018-2025.North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas Asia Pacific is expected to witness highest growth owing to factors such as, increasing focus of industry players to expand in India & Japan and improving regulatory policies that are favorable for conducting clinical trials along with a large pool of patient participants.
Market Insights
Increasing R&D Expenditures and Outsourcing Activities
Research and development (R&D) is an essential and crucial part of the company’s business. Pharmaceutical and biotech companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies invest majorly on the R&Ds with the aim of delivering high quality and innovative products to the market. Research and development expenditures relate to the processes of discovering, testing and developing new products, upfront payments and milestones, improving existing products, as well as demonstrating product efficacy and regulatory compliance prior to launch. According to the International Federation of Pharmaceutical Manufacturers & Associations, the R&D expenditures in 2014 by the pharmaceuticals and biotechnology industry grew by approximately 8.7% than that of the expenditures in 2013. Moreover, in United States, investments for R&D by pharmaceutical companies had grown consistently over the last 15 years. The intensity for R&D by the companies in Japan accounted for about 13.3%, in US it accounted approximately 17% and in the European Union it was registered to be approximately 13% in the year 2014.
Get Sample Copy of this Report at https://bit.ly/2FGotq9
Rise in the Number of Clinical Trials
Clinical trials are the crucial and significant step in discovering whether the medical strategy, treatment, or device is safe and effective for human use. The clinical studies help in understanding and determining the best medical approaches for certain therapeutic area. Clinical trials are conducted primarily to collect data regarding the safety and efficacy of new drug and device development. Before the approval of drug molecules and the medical devices by the regulatory authorities, series of clinical studies are conducted. Increasing prevalence of various communicable and non-communicable diseases are increasing the demand for the development of new drugs or medical devices for the treatment. This is in turn expected to increase the demand of the clinical trial activities for various therapeutic areas. As per the US National Library of Medicine presently approximately, 280, 801 clinical studies have been listed with locations of 50 states and 204 countries in till 2018. The number of registered studies by August 2018, is shows the rise in the number of the registration for the clinical trials.
Key Benefits-
• To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Contract Research Organization (CRO) Market.
• To forecast the size of the market segments with respect to four major regional segments, namely, North
Type Insights
In 2017, the clinical research services segment held a largest market share of 54.4% of the contract research organization (CRO) market, by product. This segment is also expected to dominate the market in 2025. This is primarily attributed the increasing number of new drug molecules and medical devices for the treatment of various therapeutic areas and the requirement for the fulfillment of stringent regulatory requirements before product approvals. However, the laboratory services segment is anticipated to witness the fastest growth rate of 10.3% during the forecast period, 2018 to 2025.
Inquire Before Buying@ https://bit.ly/2uwAWWW
End User Insights
Drug discovery services segment is anticipated to grow at a CAGR of 7.7% during the forecast period. Increasing R&D expenditure by the pharmaceutical companies and increasing demand of outsourcing of services to the CROs to save time and cost is expected to boost the demand for these services in the coming years.
Strategic Insights
Product approvals and acquisitions were observed as the most adopted strategy in global contract research organization industry. Few of the product approvals and acquisitions made by the players in the market are listed below;
2018: In June, 2018, Laboratory Corporation of America Holdings acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions for biopharmaceutical and medical devices clients. Sciformix has become part of Covance, Laboratory Corporation of America Holdings’s drug development business.
2018: In June, IQVIA launched Virtual Research Solutions, a new suite of technology-led study options offering advances in patient-centric trial design and execution. Powered by the IQVIA CORE, Virtual Research Solutions combines unparalleled information assets, advanced analytics, technologies and critical domain expertise to design and execute trials and late-phase studies.
CONTRACT RESEARCH ORGANIZATION – MARKET SEGMENTATION
By Type
Clinical Research Services
Early Phase Development Services
Laboratory Services
Post-Approval Services
By End User
Pharmaceutical & Biotechnology Companies
Medical Device Companies
By Geography
Buy this Report now at https://bit.ly/2OwXdgs
North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Asia Pacific (APAC)
China
India
Japan
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
South America (SAM)
Brazil
Argentina
Company Profiles
IQVIA
Laboratory Corporation of America Holdings
PAREXEL International Corporation
Syneos Health
PRA Health Sciences
Charles River
ICON plc
Pharmaceutical Product Development, LLC
WuXi AppTec
Medpace
About us: -
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact us: -
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Contract Research Organization (CRO) Market SWOT Analysis to 2025 Lead by IQVIA, Syneos Health, Laboratory Corporation, PRA Health Sciences, Charles River, ICON plc, WuXi AppTec,Medpace here
News-ID: 1677449 • Views: …
More Releases from The Insight Partners

Concentrated Nitric Acid Market Research is expecting to accrue strong growth in …
The Insight Partners has added Latest Report on "Concentrated Nitric Acid Market". Research Report mainly includes Size, Share, growth Factors, sales, Demand, Revenue, Trade, Forecast and Global companies Analysis. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability across different…

Nut-Based Spreads Market on a Growth Trajectory, Spurred by Health-Focused Diets …
According to a new report from The Insight Partners, titled "Nut Based Spreads Market - Global Analysis and Forecast," the global market for nut-based spreads is advancing toward significant growth. The report indicates that this market progression is being spurred by the rising trend of health-conscious eating and the increasing appeal of plant-based and vegan diets.
Download Sample PDF Copy At: https://www.theinsightpartners.com/sample/TIPRE00010071/?utm_source=OpenPR&utm_medium=10752
Health-Conscious Eating and Veganism Ignite Market Momentum
The market for nut-based…

Global Instant Noodles Market: Trends Shaping the Future of Convenience Foods
The global instant noodles market is a growing segment in the broader food industry, owing to urbanization, changing lifestyles, and a surge in demand for convenient and affordable meal options. The primary consumers in urban areas are students and working professionals seeking quick meal solutions, owing to their significant popularity in younger demographics and lower to middle-income groups, as the product is affordable and easy to prepare. Moreover, the rising…

Driving Efficiency: Trends Shaping the Global Truck Loading Market
Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability…
More Releases for CRO
Global Veterinary CRO & CDMO Market Size & Trends
According to a new market research report published by Global Market Estimates, the global veterinary CRO & CDMO market is expected to grow at a CAGR of 9.1% from 2023 to 2028.
The growing awareness regarding the importance of animal health and welfare has led to increased investments in veterinary pharmaceutical research and development. This awareness is driven by the rising concern for the well-being of pets, livestock, and animals used…
Global Contract Research Organization (CRO) Services Market
According to a new market research report published by Global Market Estimates, the Global Contract Research Organization (CRO) Services Market is expected to grow at a CAGR of 10.2% from 2023 to 2028.
The growth of the contract research organization (CRO) Services Market is fuelled by factors including the rising preference for outsourcing clinical trials, increasing investments in research and development by pharmaceutical and biopharmaceutical companies, the growing complexities in drug…
Contract Research Organization (CRO) Services Market - Efficiency, Expertise, Ex …
Newark, New Castle, USA: The "Contract Research Organization (CRO) Services Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Contract Research Organization (CRO) Services Market: https://www.growthplusreports.com/report/contract-research-organization-cro-services-market/7630
This latest report…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer.
Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continues…
Partnership factors in sponsor – CRO relationships
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CRO’s have been increasingly used by larger pharma to outsource their clinical research, allowing big pharma to shut down in-house R&D, in practice saving money.
There have been some issues however with the outsourcing of trials to CROs, including serious relationship break down with negative attitudes, failure to communicate…